Authors: Stecklair, KP Hamburger, DR Egorin, MJ Parise, RA Covey, JM Eiseman, JL

Citation: Kp. Stecklair et al., Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats, CANC CHEMOT, 48(5), 2001, pp. 375-382

Authors: Koch, CJ Hahn, SM Rockwell, K Covey, JM McKenna, WG Evans, SM

Citation: Cj. Koch et al., Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitrolmidazoles, CANC CHEMOT, 48(3), 2001, pp. 177-187

Authors: Egorin, MJ Zuhowski, EG Rosen, DM Sentz, DL Covey, JM Eiseman, JL

Citation: Mj. Egorin et al., Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1, CANC CHEMOT, 47(4), 2001, pp. 291-302

Authors: Walker, DL Reid, JM Svingen, PA Rios, R Covey, JM Alley, MC Hollingshead, MG Budihardjo, II Eckdahl, S Boerner, SA Kaufmann, SH Ames, MM

Citation: Dl. Walker et al., Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent, BIOCH PHARM, 58(6), 1999, pp. 1057-1066